Cart
sales@molnova.com
Bucetin
CAS No. 1083-57-4
Bucetin( —— )
Catalog No. M10330 CAS No. 1083-57-4
Bucetin is a pharmaceutical drug that acts as an analgesic and antipyretic.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 29 | In Stock |
|
| 100MG | 28 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 62 | In Stock |
|
| 1G | 91 | In Stock |
|
Biological Information
-
Product NameBucetin
-
NoteResearch use only, not for human use.
-
Brief DescriptionBucetin is a pharmaceutical drug that acts as an analgesic and antipyretic.
-
DescriptionBucetin is a pharmaceutical drug that acts as an analgesic and antipyretic. Chemically, it is similar to phenacetin with which it shares the risk of carcinogenesis. Bucetin was withdrawn from use in 1986 due to renal toxicity.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research AreaOther Indications
-
Indication——
Chemical Information
-
CAS Number1083-57-4
-
Formula Weight223.27
-
Molecular FormulaC12H17NO3
-
Purity>98% (HPLC)
-
SolubilityDMSO: 10 mM
-
SMILESCCOC1=CC=C(NC(=O)CC(C)O)C=C1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Togei, K, et al. Journal of the National Y Institute, 79 (5): 1151–8.
molnova catalog
related products
-
LSKL(a)
LSKL Inhibitor of Thrombospondin (TSP-1) is a peptide derived from the latency-associated peptide inhibits thrombospondin (TSP-1) activation of TGF-β.
-
Panasenoside
Panasenoside is a natural product.
-
AUNP-12 TFA
AUNP-12 TFA (NP-12 TFA) is a polypeptide antagonist in the pd-1 signaling pathway, which has the same antagonistic effect on pd-l1 and pd-l2, and can protect the proliferation and effector function of lymphocytes.
